This initiative supports Astra Biotech’s aim of facilitating early diagnosis of individuals’ risk factors through innovative assays. In this way long-term effects of a disease can be minimised and ...
Twenty-one weeks into her pregnancy, Barbara Farlow discovered that her daughter Annie would be born with the genetic disorder trisomy 13, a chromosomal abnormality — and a label — that would ...
TORONTO, Sept. 21 /CNW/ - SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Health Canada has issued ...
Would you want to know if your unborn baby is at risk of autism? Researchers wrapping up a 4,406-patient study say that a new genetic test that analyzes fetal DNA in more detail than current prenatal ...
PathogenDx has announced the release of the first quantitative microarray-based test for cannabis, PDx-Quant™, which can determine whether or not a sample exceeds a state or a federal regulatory ...
CombiMatrix announced earlier that the American College of Obstetricians and Gynecologists, ACOG, has issued new guidelines indicating that chromosomal microarray analysis is now recommended as the ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global genetic testing market is growing at a ...
IRVINE, Calif., June 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, ...